Daclatasvir Impurity F

Product Description
CAT No.
ALN-D036033
CAS No.
2077207-88-4
Mol. F.
C41H52N8O6
Mol. Wt.
752.9
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : Methyl ((2S,3S)-1-((S)-2-(4-(4′-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1′-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxopentan-2-yl)carbamate
Smiles : [H][C@@]1(N(C([C@@]([H])(NC(OC)=O)[C@](C)([H])CC)=O)CCC1)C2=NC(C3=CC=C(C=C3)C4=CC=C(C5=CNC([C@@]6([H])N(C([C@](NC(OC)=O)([H])C(C)C)=O)CCC6)=N5)C=C4)=CN2
Technical Data
Reference
A validated stability-indicating reverse-phase high-performance liquid chromatography method for daclatasvir, identification and characterization of degradation products using LC-ESI-QTOF-MS
By Warghade, Snehal V.; Bothara, Kailash G.nFrom Asian Journal of Pharmaceutical and Clinical Research (2019), 12(5), 302-308
Development and validation of HPLC fluorescence and UPLC/DAD stability-indicating methods for determination of hepatitis C antiviral agent daclatasvir
By Kamal, Andra H.; Ismail, Nahla S.; Mabroijk, Mokhtar M.; Bebawy, Lories I.; Mekky, Mai A. – From Journal of AOAC International (2019), 102(4), 1125-1131
A stability-indicating UPLC method for the determination of potential impurities and its mass by a new QDa mass detector in daclatasvir drug used to treat hepatitis C infection
By Jagadabi, Varaprasad; Kumar, P. V. Nagendra; Mahesh, Kasthuri; Pamidi, Srinivasu; Ramaprasad, L. A.; Nagaraju, D. – From Journal of Chromatographic Science (2019), 57(1), 44-53
RFQ